Gene · 2357
Papers4,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b. | Cardiovasc Res | 2024 | 38980770 | PubTator, text mining | PubMed |
| G protein-coupled receptors and traditional Chinese medicine: new thinks for the development of traditional Chinese medicine. | Chin Med | 2024 | 38956679 | PubTator, text mining | PubMed |
| FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization. | J Inflamm Res | 2024 | 38911989 | PubTator, text mining | PubMed |
| The Latest Advances in Ink-Based Nanogenerators: From Materials to Applications. | Int J Mol Sci | 2024 | 38892343 | PubTator, text mining | PubMed |
| Formyl Peptide Receptor 1 Inhibits Reparative Angiogenesis and Aggravates Neuroretinal Dysfunction in Ischemic Retinopathy. | Curr Eye Res | 2024 | 38856166 | PubTator, text mining | PubMed |
| Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease. | BMC Med Genomics | 2024 | 38831322 | PubTator, text mining | PubMed |
| Production of 17α-hydroxyprogesterone using an engineered biocatalyst with efficient electron transfer and improved 5-aminolevulinic acid synthesis coupled with a P450 hydroxylase. | Int J Biol Macromol | 2024 | 38825287 | PubTator, text mining | PubMed |
| Formyl-Peptide Receptor 2 Signaling Modulates SLC7A11/xCT Expression and Activity in Tumor Cells. | Antioxidants (Basel) | 2024 | 38790657 | PubTator, text mining | PubMed |
| Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice. | Thromb Haemost | 2024 | 38782024 | PubTator, text mining | PubMed |
| Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids. | Sci Adv | 2024 | 38748808 | PubTator, text mining | PubMed |
| ARAP3 protects from excessive formylated peptide-induced microvascular leakage by acting on endothelial cells and neutrophils. | J Pathol | 2024 | 38734878 | PubTator, text mining | PubMed |
| E-CLEAP: An ensemble learning model for efficient and accurate identification of antimicrobial peptides. | PLoS One | 2024 | 38722967 | PubTator, text mining | PubMed |
| Mononuclear phagocyte morphological response to chemoattractants is dependent on geranylgeranyl pyrophosphate. | Am J Physiol Endocrinol Metab | 2024 | 38717364 | PubTator, text mining | PubMed |
| Immune Characteristic Genes and Neutrophil Immune Transformation Studies in Severe COVID-19. | Microorganisms | 2024 | 38674681 | PubTator, text mining | PubMed |
| The Role of Immunocyte Infiltration Regulatory Network Based on hdWGCNA and Single-Cell Bioinformatics Analysis in Intervertebral Disc Degeneration. | Inflammation | 2024 | 38630169 | PubTator, text mining | PubMed |
| Differential gene expression and miRNA regulatory network in coronary slow flow. | Sci Rep | 2024 | 38600259 | PubTator, text mining | PubMed |
| Skin barrier dysfunction drives skin inflammation via formylpeptide receptor 1. | Br J Dermatol | 2024 | 38488647 | PubTator, text mining | PubMed |
| FPR1: A critical gatekeeper of the heart and brain. | Pharmacol Res | 2024 | 38438091 | PubTator, text mining | PubMed |
| Workshop report: the clinical application of data from multiplex assays of variant effect (MAVEs), 12 July 2023. | Eur J Hum Genet | 2024 | 38433264 | PubTator, text mining | PubMed |
| Clinical Efficacy and Mechanism of Vitamin D2 in Treating Hashimoto's Thyroiditis. | J Inflamm Res | 2024 | 38410421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2357/papers?page=14